The Experts below are selected from a list of 5199 Experts worldwide ranked by ideXlab platform
Brian Sloan - One of the best experts on this subject based on the ideXlab platform.
-
Acute Dacryocystitis presenting as an orbital abscess.
Clinical & experimental ophthalmology, 2002Co-Authors: Sajid Ataullah, Brian SloanAbstract:Acute Dacryocystitis usually presents as a preseptal infection, but can uncommonly be associated with orbital cellulitis. Orbital abscess formation is, however, very rare. The case is presented of a 60-year-old woman with an extraconal abscess secondary to acute Dacryocystitis. The clinical, radiological and intraoperative findings are discussed.
Sajid Ataullah - One of the best experts on this subject based on the ideXlab platform.
-
Acute Dacryocystitis presenting as an orbital abscess.
Clinical & experimental ophthalmology, 2002Co-Authors: Sajid Ataullah, Brian SloanAbstract:Acute Dacryocystitis usually presents as a preseptal infection, but can uncommonly be associated with orbital cellulitis. Orbital abscess formation is, however, very rare. The case is presented of a 60-year-old woman with an extraconal abscess secondary to acute Dacryocystitis. The clinical, radiological and intraoperative findings are discussed.
Zhang Man-pin - One of the best experts on this subject based on the ideXlab platform.
-
Observation of effect of chronic Dacryocystitis treated by nasolacrimal stent
Clinical Ophthalmology, 2010Co-Authors: Zhang Man-pinAbstract:Objective To observe the curative effect of chronic Dacryocystitis treatedby nasolacrimal stent.Methods 37 patients(52eyes) of chronic Dacryocystitis were placed nasolacrimal stent.Results Results after following up for 3 months to 1 years,forty-nine of 52eyes with chronic Dacryocystitis were cured,2 improved eyes andone ineffective eye,the total effective rate reaching 98%.Conclusion Using nasolac-rimal stent is a minimally invasive surgery,safe,simple and effective methods totreat chronic Dacryocystitis.
Igal Leibovitch - One of the best experts on this subject based on the ideXlab platform.
-
External Dacryocystorhinostomy: Characteristics and Surgical Outcomes in Patients with and without Previous Dacryocystitis
Journal of ophthalmology, 2013Co-Authors: Gilad Rabina, Shani Golan, Meira Neudorfer, Igal LeibovitchAbstract:Objective. To compare pre- and postoperative characteristics and surgical success rates of patients with and without previous episodes of Dacryocystitis, who underwent external dacryocystorhinostomy (DCR) for nasolacrimal duct obstruction (NLDO). Methods. The medical files of all patients who underwent external DCR between 2006 and 2011 in our institution were reviewed. The retrieved data of patients with and without previous episodes of Dacryocystitis were compared. Surgical success was determined by postoperative followup of at least 6 months. Results. A total of 185 patients with NLDO underwent external DCR of whom 152 (100 females and 52 males, mean age 67 ± 15 years) met the inclusion criteria. Sixty had previous episodes of Dacryocystitis and 92 did not. Left-side obstruction was more common than right-side obstruction among patients with previous episodes of Dacryocystitis (48.3% versus 31.7%, resp., P = 0.031). Glaucoma patients were significantly more likely to develop Dacryocystitis than patients without glaucoma (P = 0.002). The success rate of external DCR was 94.4% for patients with previous episodes of Dacryocystitis and 86.7% for patients without (P = 0.337). Conclusions. The surgical outcomes of external DCR in patients with or without a previous episode of Dacryocystitis were similar. Patients with glaucoma and NLDO had a significantly higher risk of developing Dacryocystitis.
Vijay Kumar - One of the best experts on this subject based on the ideXlab platform.
-
Ophthacare in Pterygium and Dacryocystitis
1998Co-Authors: Vijay KumarAbstract:Dacryocystitis and pterygium are common ophthalmic disorders encountered in daily practice. Effective local antibacterial and anti-inflammatory therapy brings down the inflammation and infection and avoids the risks associated with surgery. Ophthacare, a herbal preparation, with its proven antiinflammatory and antibacterial activity was used in the management of acute/chronic Dacryocystitis and pterygium. The results showed that it was effective in relieving the symptoms within 8-10 days in Dacryocystitis and within 15 days in case of pterygium. Thus Ophthacare can be safely used in conservative management of acute/chronic Dacryocystitis and pterygium.
-
Ophthacare in Pterygium and Dacryocystitis
1998Co-Authors: Vijay KumarAbstract:Dacryocystitis and pterygium are common ophthalmic disorders encountered in daily practice. Effective local antibacterial and anti-inflammatory therapy brings down the inflammation and infection and avoids the risks associated with surgery. Ophthacare, a herbal preparation, with its proven antiinflammatory and antibacterial activity was used in the management of acute/chronic Dacryocystitis and pterygium. The results showed that it was effective in relieving the symptoms within 8-10 days in Dacryocystitis and within 15 days in case of pterygium. Thus Ophthacare can be safely used in conservative management of acute/chronic Dacryocystitis and pterygium.
